This course is Lesson 4 of a recently completed webinar entitled, "Nutritional Challenges in Chronic Kidney Disease." Successfully completing this lesson will earn 1.5 CEs. For accreditation information and presenter biographies, Click here.

Topics:

I. Prevalence of bone disease/mineral disregulation in CKD
II. Causes of bone disease in the CKD patient

A. Phosphorus retention
B. Vitamin D deficiency
C. Secondary hyperparathyroidism

III. Types of bone disease in the CKD patient

A. Hyperparathyroidism
B. Osteomalacia
C. Adynamic bone disease
D. Mixed osteodystrophy

IV. Guidelines of bone metabolism in CKD

A. Goals for PTH
B. Goals for calcium X phosphorus
C. Goals for calcium
D. Goals for phosphorus

V. Medications used in the treatment of bone metabolism disregulation

A. Binders

• Calcium based
• Sevelamer Hydrochloride
• Sevelamer Carbonate
• Lanthanum Carbonate

B. Vitamin D

• Calcitriol
• Zemplar
• Hectorol

C. Calcimimetics

• Sensipar

VI. Case studies on bone metabolism management in CKD.

Behavioral/Learning Objectives:

1. Describe the prevalence of bone disease/mineral disregulation in CKD
2. List the causes and types of bone disease.
3. Identify the guidelines of bone metabolism in CKD
4. Identify medications used in the treatment of bone metabolism disregulation.